Cargando…

Prognostic prediction of subjective cognitive decline in major depressive disorder based on immune biomarkers: a prospective observational study

OBJECTIVE: Subjective cognitive decline (SCD) is highlighted in patients with major depressive disorder (MDD), which impairs objective cognitive performance and worsens the clinical outcomes. Immune dysregulation is supposed to be the potential mechanism of cognitive impairment. However, the periphe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Meiti, Wei, Zheyi, Huang, Qinte, Yang, Weijie, Wu, Chenglin, Cao, Tongdan, Zhao, Jie, Lyu, Dongbin, Wang, Fan, Zhou, Ni, Huang, Haijing, Zhang, Mengke, Chen, Yiming, Xu, Yi, Ma, Weiliang, Chen, Zheng, Hong, Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850523/
https://www.ncbi.nlm.nih.gov/pubmed/36658505
http://dx.doi.org/10.1186/s12888-022-04513-x
_version_ 1784872204390891520
author Wang, Meiti
Wei, Zheyi
Huang, Qinte
Yang, Weijie
Wu, Chenglin
Cao, Tongdan
Zhao, Jie
Lyu, Dongbin
Wang, Fan
Zhou, Ni
Huang, Haijing
Zhang, Mengke
Chen, Yiming
Xu, Yi
Ma, Weiliang
Chen, Zheng
Hong, Wu
author_facet Wang, Meiti
Wei, Zheyi
Huang, Qinte
Yang, Weijie
Wu, Chenglin
Cao, Tongdan
Zhao, Jie
Lyu, Dongbin
Wang, Fan
Zhou, Ni
Huang, Haijing
Zhang, Mengke
Chen, Yiming
Xu, Yi
Ma, Weiliang
Chen, Zheng
Hong, Wu
author_sort Wang, Meiti
collection PubMed
description OBJECTIVE: Subjective cognitive decline (SCD) is highlighted in patients with major depressive disorder (MDD), which impairs objective cognitive performance and worsens the clinical outcomes. Immune dysregulation is supposed to be the potential mechanism of cognitive impairment. However, the peripheral immune biomarkers in patients troubled with MDD and SCD are not conventionally described. METHODS: A prospective-observational study was conducted for 8 weeks. Subjective cognitive function was measured using the Chinese version of the 20-item perceived deficits questionnaire-depression (PDQ-D) and depression symptoms were evaluated with Hamilton Depression Rating Scale-17 (HDRS-17). Luminex assays were used to measure 48 immune cytokines in plasma at baseline. Integrating these results and clinicopathological features, a logistic regression model was used to develop a prognostic prediction. RESULTS: Totally, 114 patients were enrolled in this study. Among the patients who completed follow-up, 56% (N = 50) had residual subjective cognitive decline, and 44% (N = 50) did not. The plasma levels of FGF basic, INF-γ, IL-1β, MCP-1, M-CSF and SCF were increased and the levels of IL-9, RANTES and PDGF-BB were decreased in the SCD group. Additionally, Basic FGF, IFN-γ, IL-1β, and SCF were positively correlated and IL-9, RANTES, and PDGF-BB were negatively correlated with the PDQ-D scores after treatment. Notably, combinations of cytokines (SCF and PDGF-BB) and PDQ-D scores at baseline showed good performance (The area under the receiver operating characteristic curve = 0.818) in the prediction of subjective cognitive decline. CONCLUSION: A prognostic model based on protein concentrations of SCF, PDGF-BB, and scores of PDQ-D showed considerable accuracy in predicting residual subjective cognitive decline in depression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-04513-x.
format Online
Article
Text
id pubmed-9850523
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98505232023-01-20 Prognostic prediction of subjective cognitive decline in major depressive disorder based on immune biomarkers: a prospective observational study Wang, Meiti Wei, Zheyi Huang, Qinte Yang, Weijie Wu, Chenglin Cao, Tongdan Zhao, Jie Lyu, Dongbin Wang, Fan Zhou, Ni Huang, Haijing Zhang, Mengke Chen, Yiming Xu, Yi Ma, Weiliang Chen, Zheng Hong, Wu BMC Psychiatry Research OBJECTIVE: Subjective cognitive decline (SCD) is highlighted in patients with major depressive disorder (MDD), which impairs objective cognitive performance and worsens the clinical outcomes. Immune dysregulation is supposed to be the potential mechanism of cognitive impairment. However, the peripheral immune biomarkers in patients troubled with MDD and SCD are not conventionally described. METHODS: A prospective-observational study was conducted for 8 weeks. Subjective cognitive function was measured using the Chinese version of the 20-item perceived deficits questionnaire-depression (PDQ-D) and depression symptoms were evaluated with Hamilton Depression Rating Scale-17 (HDRS-17). Luminex assays were used to measure 48 immune cytokines in plasma at baseline. Integrating these results and clinicopathological features, a logistic regression model was used to develop a prognostic prediction. RESULTS: Totally, 114 patients were enrolled in this study. Among the patients who completed follow-up, 56% (N = 50) had residual subjective cognitive decline, and 44% (N = 50) did not. The plasma levels of FGF basic, INF-γ, IL-1β, MCP-1, M-CSF and SCF were increased and the levels of IL-9, RANTES and PDGF-BB were decreased in the SCD group. Additionally, Basic FGF, IFN-γ, IL-1β, and SCF were positively correlated and IL-9, RANTES, and PDGF-BB were negatively correlated with the PDQ-D scores after treatment. Notably, combinations of cytokines (SCF and PDGF-BB) and PDQ-D scores at baseline showed good performance (The area under the receiver operating characteristic curve = 0.818) in the prediction of subjective cognitive decline. CONCLUSION: A prognostic model based on protein concentrations of SCF, PDGF-BB, and scores of PDQ-D showed considerable accuracy in predicting residual subjective cognitive decline in depression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-04513-x. BioMed Central 2023-01-19 /pmc/articles/PMC9850523/ /pubmed/36658505 http://dx.doi.org/10.1186/s12888-022-04513-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Meiti
Wei, Zheyi
Huang, Qinte
Yang, Weijie
Wu, Chenglin
Cao, Tongdan
Zhao, Jie
Lyu, Dongbin
Wang, Fan
Zhou, Ni
Huang, Haijing
Zhang, Mengke
Chen, Yiming
Xu, Yi
Ma, Weiliang
Chen, Zheng
Hong, Wu
Prognostic prediction of subjective cognitive decline in major depressive disorder based on immune biomarkers: a prospective observational study
title Prognostic prediction of subjective cognitive decline in major depressive disorder based on immune biomarkers: a prospective observational study
title_full Prognostic prediction of subjective cognitive decline in major depressive disorder based on immune biomarkers: a prospective observational study
title_fullStr Prognostic prediction of subjective cognitive decline in major depressive disorder based on immune biomarkers: a prospective observational study
title_full_unstemmed Prognostic prediction of subjective cognitive decline in major depressive disorder based on immune biomarkers: a prospective observational study
title_short Prognostic prediction of subjective cognitive decline in major depressive disorder based on immune biomarkers: a prospective observational study
title_sort prognostic prediction of subjective cognitive decline in major depressive disorder based on immune biomarkers: a prospective observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850523/
https://www.ncbi.nlm.nih.gov/pubmed/36658505
http://dx.doi.org/10.1186/s12888-022-04513-x
work_keys_str_mv AT wangmeiti prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT weizheyi prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT huangqinte prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT yangweijie prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT wuchenglin prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT caotongdan prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT zhaojie prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT lyudongbin prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT wangfan prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT zhouni prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT huanghaijing prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT zhangmengke prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT chenyiming prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT xuyi prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT maweiliang prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT chenzheng prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy
AT hongwu prognosticpredictionofsubjectivecognitivedeclineinmajordepressivedisorderbasedonimmunebiomarkersaprospectiveobservationalstudy